Daiwa Securities Group’s Immunocore IMCR Stock Holding History

Daiwa Securities Group’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-138	Closed	-$5K	–	1301
2025 Q4	$5K	Hold	138	–	–	﹤0.01%	1236
2025 Q3	$5K	Hold	138	–	–	﹤0.01%	1204
2025 Q2	$4K	Hold	138	–	–	﹤0.01%	1172
2025 Q1	$4K	Hold	138	–	–	﹤0.01%	1148
2024 Q4	$4K	Hold	138	–	–	﹤0.01%	1175
2024 Q3	$4K	Hold	138	–	–	﹤0.01%	1186
2024 Q2	$5K	Hold	138	–	–	﹤0.01%	1197
2024 Q1	$9K	Hold	138	–	–	﹤0.01%	1173
2023 Q4	$9K	Buy	138 +34	+33%	+$1.77K	﹤0.01%	1173
2023 Q3	$5K	Hold	104	–	–	﹤0.01%	1157
2023 Q2	$6K	Hold	104	–	–	﹤0.01%	1166
2023 Q1	$5K	Hold	104	–	–	﹤0.01%	1151
2022 Q4	$6K	Buy	+104	New	+$5.85K	﹤0.01%	1141

Other funds holding IMCR

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Daiwa Securities Group's IMCR Position: Q1 2026 in Review

Daiwa Securities Group sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 138 shares — an estimated $5K sold.

Daiwa Securities Group first reported a position in IMCR in Q4 2022 and held it in 13 quarters. The position peaked at $9K in Q1 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Daiwa Securities Group reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 138 Immunocore shares in Q1 2026, an estimated $5K.
Daiwa Securities Group first reported a position in Immunocore in Q4 2022 and held it in 13 quarters.
Daiwa Securities Group's Immunocore position peaked at $9K in Q1 2024.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.